<amendment session="112" chamber="s" number="2125" updated="2022-02-25T17:31:35Z">
  <amends type="s" number="3187" sequence=""/>
  <status datetime="2012-05-23">pass</status>
  <sponsor bioguide_id="C000141"/>
  <offered datetime="2012-05-21"/>
  <description>To ensure that adequate information is disseminated to health care providers and payors about the potential benefits and risks of medical products on all patient populations, particularly underrepresented subpopulations, including racial subgroups.</description>
  <actions>
    <vote datetime="2012-05-23" how="Unanimous Consent" result="pass">
      <text>Amendment SA 2125 agreed to in Senate by Unanimous Consent.</text>
    </vote>
    <action datetime="2012-05-23">
      <text>Amendment SA 2125 proposed by Senator Cardin. (consideration: CR S3497, S3500, S3507; text: CR S3497) To ensure that adequate information is disseminated to health care providers and payors about the potential benefits and risks of medical products on all patient populations, particularly underrepresented subpopulations, including racial subgroups.</text>
    </action>
    <action datetime="2012-05-23">
      <text>Senate amendment proposed (on the floor): Amendment SA 2125 proposed by Senator Cardin.</text>
      <reference ref="CR S3497, S3500, S3507" label="consideration"/>
      <reference ref="CR S3497" label="text"/>
    </action>
    <action datetime="2012-05-23">
      <text>Senate amendment agreed to: Amendment SA 2125 agreed to in Senate by Unanimous Consent.</text>
    </action>
    <action datetime="2012-05-21">
      <text>Senate amendment submitted</text>
    </action>
  </actions>
</amendment>
